Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Connection

Brian Freed to Immunosuppressive Agents

This is a "connection" page, showing publications Brian Freed has written about Immunosuppressive Agents.

 
Connection Strength
 
 
 
0.500
 
  1. McCue JM, Link KL, Eaton SS, Freed BM. Exposure to cigarette tar inhibits ribonucleotide reductase and blocks lymphocyte proliferation. J Immunol. 2000 Dec 15; 165(12):6771-5.
    View in: PubMed
    Score: 0.123
  2. Freed BM, Bennett JA, Rosano TG, Brooks CA, Cramer SM, Lempert N. Assessment of the in vivo immunosuppressive activity of the major cyclosporine metabolite by leukemia allograft rejection. Transplantation. 1992 Feb; 53(2):456-60.
    View in: PubMed
    Score: 0.066
  3. Stevens C, Lempert N, Freed BM. The effects of immunosuppressive agents on in vitro production of human immunoglobulins. Transplantation. 1991 Jun; 51(6):1240-4.
    View in: PubMed
    Score: 0.063
  4. Freed BM, Mozayeni B, Lawrence DA, Wallach FR, Lempert N. Differential inhibition of human T-lymphocyte activation by maleimide probes. Cell Immunol. 1986 Aug; 101(1):181-94.
    View in: PubMed
    Score: 0.045
  5. Lambert C, McCue J, Portas M, Ouyang Y, Li J, Rosano TG, Lazis A, Freed BM. Acrolein in cigarette smoke inhibits T-cell responses. J Allergy Clin Immunol. 2005 Oct; 116(4):916-22.
    View in: PubMed
    Score: 0.042
  6. Isenberg A, Singh TP, Shen GK, Freed BM, Conti DJ. Selective CellCept therapy in high-risk renal transplant recipients. Transplant Proc. 1998 Jun; 30(4):1188-9.
    View in: PubMed
    Score: 0.026
  7. Davis S, Gralla J, Klem P, Tong S, Wedermyer G, Freed B, Wiseman A, Cooper JE. Lower tacrolimus exposure and time in therapeutic range increase the risk of de novo donor-specific antibodies in the first year of kidney transplantation. Am J Transplant. 2018 04; 18(4):907-915.
    View in: PubMed
    Score: 0.025
  8. Kasten-Jolly J, Aubrey MT, Conti DJ, Rosano TG, Ross JS, Freed BM. Reversal of hyperglycemia in diabetic NOD mice by human proinsulin gene therapy. Transplant Proc. 1997 Jun; 29(4):2216-8.
    View in: PubMed
    Score: 0.024
  9. Conti DJ, Shen G, Singh T, Isenberg A, Freed BM. Ganciclovir prophylaxis of cytomegalovirus disease. Transplant Proc. 1997 Feb-Mar; 29(1-2):804-6.
    View in: PubMed
    Score: 0.023
  10. Hughes SE, Xiao S, Perera S, Fluno C, Hasselbarth J, Jayasankar V, Singh J, Del Rosario A, Freed BM, Singh TP, Lempert N, Conti DJ, Gruber SA. Local immunosuppression of canine renal allografts with 15-deoxyspergualin. Transplant Proc. 1996 Aug; 28(4):2054-5.
    View in: PubMed
    Score: 0.023
  11. Gruber SA, Gallichio M, Rosano TG, Hughes SE, Singh TP, Lempert N, Conti DJ, Hasselbarth J, Freed BM, Stein D, Drusano G. Comparative pharmacokinetics of cyclosporine A and cyclosporine G in renal allograft recipients. Transplant Proc. 1996 Apr; 28(2):892.
    View in: PubMed
    Score: 0.022
  12. Freed BM, Rosano TG, Quick C, Lempert N. Effects of cyclosporine metabolites M17 and M18 on proliferation and interleukin 2 production in the mixed lymphocyte culture. Transplant Proc. 1987 Feb; 19(1 Pt 2):1223-6.
    View in: PubMed
    Score: 0.012
  13. Conti DJ, Freed BM, Gruber SA, Singh TP, Gallichio M, Lempert N. Impact of retransplant status on delayed graft function: an analysis of paired cadaver kidneys. Transplant Proc. 1995 Feb; 27(1):1070-1.
    View in: PubMed
    Score: 0.005
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.

Copyright © 2025 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)